Skip to main content
Clinical Trials/NCT04608617
NCT04608617RecruitingNot Applicable

Observational Study of Automated Detection for Identification, Triage, and Timely Intervention in Large Vessel Occlusions- SYNCHRONISE

Viz.ai, Inc.3 sites in 1 country1,000 target enrollmentStarted: March 9, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
1,000
Locations
3
Primary Endpoint
Transfer patients: Time from spoke CT/CTA to door-out

Study Overview

Brief Summary

The objective of this study is to evaluate the impact of Viz LVO in hospital systems with non-interventional and interventional (spoke and hub) stroke centers on the timing and outcomes of patients with suspected acute ischemic stroke indicated for mechanical thrombectomy.

Detailed Description

This is a multi-center, non-randomized observational study of acute ischemic stroke patients whose CTA scans are analyzed by Viz LVO to support clinicians in making stroke triage decisions,. The study results will be compared to a cohort from enrolling centers prior to Viz LVO implementation that will serve as a historical control. Data will be collected retrospectively from the time of presentation through 90 days post discharge.

The study will include patients undergoing imaging for a suspected LVO acute ischemic stroke. The post-Viz LVO intervention group will consist of patients who either presented to or underwent transfer to an interventional center, from a non-interventional center, following image analysis by Viz LVO. Data will be collected retrospectively on consecutive patients meeting eligibility criteria from the date of implementation up to 5 years post implementation.

The control group will consist of patients who either presented to or underwent transfer to an interventional center, from a non-interventional center, for evaluation prior to the implementation of Viz LVO. Data will be collected on consecutive patients from one day prior to implementation, back as far as 2 years prior to implementation

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age of 18 years or greater
  • Signs and symptoms consistent with the diagnosis of a large vessel occlusive stroke
  • Pre-treatment National Institutes of Health Stroke Scale (NIHSS) ≥ 6
  • Aspects Score ≥6
  • Patient must have a suspected LVO in M
  • Patient with an intention to treat with mechanical thrombectomy with confirmation of LVO by the CT/CTA radiographic report with the reading diagnosis.

Exclusion Criteria

  • Unable to undergo a brain imaging (i.e. severe contrast medium allergy, claustrophobia)

Outcomes

Primary Outcomes

Transfer patients: Time from spoke CT/CTA to door-out

Time Frame: up to 1 day (1440 minutes)

Time in minutes from CT/CTA imaging to time leaving the spoke center

Non-transfer patients: Time from Hub door to groin puncture

Time Frame: up to 1 day (1440 minutes)

Time in minutes from arrival a hub center to start time of treatment

Secondary Outcomes

  • Time from Spoke Door to Groin Puncture(up to 1 day (1440 minutes))
  • Length of ICU Stay/Total Length of Stay(Hospital admit to discharge, up to 30 days)
  • Modified Rankin Scale (mRS) at Discharge and 90 Days(90 days)
  • Time from Spoke Door-In to Door-Out (DIDO)(up to 1 day (1440 minutes))
  • Time from Spoke CT/CTA to Groin Puncture(up to 1 day (1440 minutes))
  • Time from Spoke CT/CTA to Specialist Notification(up to 1 day (1440 minutes))
  • National Institutes of Health Stroke Scale (NIHSS) at Discharge(On date of discharge, up to 30 days)
  • Patient Disposition at Discharge and 90 Days(90 days)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (3)

Loading locations...

Similar Trials

SYNCHRONISE: LVO Triage Timing and Outcome... | Clinical Trial